Close Menu

NEW YORK (GenomeWeb) – InSilixa announced yesterday that it has received a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health to develop a point-of-care molecular diagnostic test for the rapid detection and profiling of antibiotic-resistant Mycobacterium tuberculosis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.